cvs caremark glp 1 coverage glp-1 2026 CVS Caremark has announced a formulary change affecting obesity treatment. Effective July 1, Wegovy will replace Zepbound as the preferred GLP-1 medication for Alternative GLP-1 medications covered by
Description
This weight reduction was significantly greater than 5.1% by semaglutide and 8.1% by cagrilintide alone therapy
Before this change, most people covered by Medicaid and CHIP paid $3 a month, the same as for brand-name medications
That means there are multiple targets. One of the reasons that GLP-1s present such a potentially promising solution is that they specifically address cravings
You want maximum weight loss with proportionally fewer GI side effects
doi:10.1016/j.bcp.2024.116170 20
95% CI, 0.37-0.83)
